Works matching AU Yau, Thomas

Results: 99
    1
    2
    3
    4
    5
    6

    An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma

    Published in:
    Oncologist, 2019, v. 24, n. 6, p. 747, doi. 10.1634/theoncologist.2018-0838
    By:
    • El Dika, Imane;
    • Lim, Ho Yeong;
    • Yong, Wei Peng;
    • Lin, Chia‐Chi;
    • Yoon, Jung‐Hwan;
    • Modiano, Manuel;
    • Freilich, Bradley;
    • Choi, Hye Jin;
    • Chao, Tsu‐Yi;
    • Kelley, Robin K.;
    • Brown, Joanne;
    • Knox, Jennifer;
    • Ryoo, Baek‐Yeol;
    • Yau, Thomas;
    • Abou‐Alfa, Ghassan K.
    Publication type:
    Article
    7

    Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 70, doi. 10.1159/000531176
    By:
    • Cheung, Tan-To;
    • Ho, Daniel Wai-Hung;
    • Lyu, Shirley Xueying;
    • Zhang, Qingyang;
    • Tsui, Yu-Man;
    • Yu, Tiffany Ching-Yun;
    • Sze, Karen Man-Fong;
    • Lee, Joyce Man-Fong;
    • Lau, Vince Wing-hang;
    • Chu, Edward Yin-Lun;
    • Tsang, Simon Hing-Yin;
    • She, Wong-Hoi;
    • Leung, Roland Ching-Yu;
    • Yau, Thomas Chung-Cheung;
    • Ng, Irene Oi-Lin
    Publication type:
    Article
    8

    Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 445, doi. 10.1159/000529824
    By:
    • Tan, Darren Jun Hao;
    • Tang, Ansel Shao Pin;
    • Lim, Wen Hui;
    • Ng, Cheng Han;
    • Nah, Benjamin;
    • Fu, Clarissa;
    • Xiao, Jieling;
    • Koh, Benjamin;
    • Tay, Phoebe Wen Lin;
    • Tan, Eunice X;
    • Teng, Margaret;
    • Syn, Nicholas;
    • Muthiah, Mark D;
    • Tamaki, Nobuharu;
    • Lee, Sung Won;
    • Kim, Beom Kyung;
    • Yau, Thomas;
    • Vogel, Arndt;
    • Loomba, Rohit;
    • Huang, Daniel Q.
    Publication type:
    Article
    9
    10

    Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 309, doi. 10.1159/000529636
    By:
    • Merle, Philippe;
    • Kudo, Masatoshi;
    • Edeline, Julien;
    • Bouattour, Mohamed;
    • Cheng, Ann-Lii;
    • Chan, Stephen Lam;
    • Yau, Thomas;
    • Garrido, Marcelo;
    • Knox, Jennifer;
    • Daniele, Bruno;
    • Breder, Valeriy;
    • Lim, Ho Yeong;
    • Ogasawara, Sadahisa;
    • Cattan, Stéphane;
    • Chao, Yee;
    • Siegel, Abby B.;
    • Martinez-Forero, Iván;
    • Wei, Ziwen;
    • Liu, Chih-Chin;
    • Finn, Richard S.
    Publication type:
    Article
    11
    12

    Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 426, doi. 10.1159/000525582
    By:
    • Yau, Thomas;
    • Tai, David;
    • Chan, Stephen Lam;
    • Huang, Yi-Hsiang;
    • Choo, Su Pin;
    • Hsu, Chiun;
    • Cheung, Tan To;
    • Lin, Shi-Ming;
    • Yong, Wei Peng;
    • Lee, Joycelyn;
    • Leung, Thomas;
    • Shum, Tracy;
    • Yeung, Cynthia S.Y.;
    • Tai, Anna Yin-Ping;
    • Law, Ada Lai Yau;
    • Cheng, Ann-Lii;
    • Chen, Li-Tzong
    Publication type:
    Article
    13
    14
    15
    16
    17

    ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928
    By:
    • Vogel, Arndt;
    • Merle, Philippe;
    • Verslype, Chris;
    • Finn, Richard S.;
    • Zhu, Andrew X.;
    • Cheng, Ann-Lii;
    • Chan, Stephen Lam;
    • Yau, Thomas;
    • Ryoo, Baek-Yeol;
    • Knox, Jennifer;
    • Daniele, Bruno;
    • Qin, Shukui;
    • Wei, Ziwen;
    • Miteva, Yanna;
    • Malhotra, Usha;
    • Siegel, Abby B.;
    • Kudo, Masatoshi
    Publication type:
    Article
    18

    ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928
    By:
    • Vogel, Arndt;
    • Merle, Philippe;
    • Verslype, Chris;
    • Finn, Richard S.;
    • Zhu, Andrew X.;
    • Cheng, Ann-Lii;
    • Chan, Stephen Lam;
    • Yau, Thomas;
    • Ryoo, Baek-Yeol;
    • Knox, Jennifer;
    • Daniele, Bruno;
    • Qin, Shukui;
    • Wei, Ziwen;
    • Miteva, Yanna;
    • Malhotra, Usha;
    • Siegel, Abby B.;
    • Kudo, Masatoshi
    Publication type:
    Article
    19
    20
    21
    22

    <sup>11</sup>C-Acetate and <sup>18</sup>F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon's Perspective.

    Published in:
    Journal of Nuclear Medicine, 2013, v. 54, n. 2, p. 192, doi. 10.2967/jnumed.112.107516
    By:
    • Tan To Cheung;
    • Chi Lai Ho;
    • Chung Mau Lo;
    • Sirong Chen;
    • See Ching Chan;
    • Chok, Kenneth S. H.;
    • Fung, James Y.;
    • Chan, Albert Chi Yan;
    • Sharr, William;
    • Yau, Thomas;
    • Poon, Ronnie T. R.;
    • Sheung Tat Fan
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.

    Published in:
    2016
    By:
    • Goh, Gerald;
    • Schmid, Ramona;
    • Guiver, Kelly;
    • Arpornwirat, Wichit;
    • Chitapanarux, Imjai;
    • Ganju, Vinod;
    • Im, Seock-Ah;
    • Kim, Sung-Bae;
    • Dechaphunkul, Arunee;
    • Maneechavakajorn, Jedzada;
    • Spector, Neil;
    • Yau, Thomas;
    • Afrit, Mehdi;
    • Ahmed, Slim Ben;
    • Johnston, Stephen R.;
    • Gibson, Neil;
    • Uttenreuther-Fischer, Martina;
    • Herrero, Javier;
    • Swanton, Charles
    Publication type:
    journal article
    33
    34

    The optimal diagnostic methods for COVID-19.

    Published in:
    Diagnosis (2194-802X), 2020, v. 7, n. 4, p. 349, doi. 10.1515/dx-2020-0058
    By:
    • Harahwa, Tinotenda A.;
    • Lai Yau, Thomas Ho;
    • Lim-Cooke, Mae-Sing;
    • Al-Haddi, Salah;
    • Zeinah, Mohamed;
    • Harky, Amer
    Publication type:
    Article
    35

    Systematic review and meta‐analysis of protein intake to support muscle mass and function in healthy adults.

    Published in:
    Journal of Cachexia, Sarcopenia & Muscle, 2022, v. 13, n. 2, p. 795, doi. 10.1002/jcsm.12922
    By:
    • Nunes, Everson A.;
    • Colenso‐Semple, Lauren;
    • McKellar, Sean R.;
    • Yau, Thomas;
    • Ali, Muhammad Usman;
    • Fitzpatrick‐Lewis, Donna;
    • Sherifali, Diana;
    • Gaudichon, Claire;
    • Tomé, Daniel;
    • Atherton, Philip J.;
    • Robles, Maria Camprubi;
    • Naranjo‐Modad, Sandra;
    • Braun, Michelle;
    • Landi, Francesco;
    • Phillips, Stuart M.
    Publication type:
    Article
    36

    A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02383-5
    By:
    • Chan, Stephen L.;
    • Schuler, Martin;
    • Kang, Yoon-Koo;
    • Yen, Chia-Jui;
    • Edeline, Julien;
    • Choo, Su Pin;
    • Lin, Chia-Chi;
    • Okusaka, Takuji;
    • Weiss, Karl-Heinz;
    • Macarulla, Teresa;
    • Cattan, Stéphane;
    • Blanc, Jean-Frederic;
    • Lee, Kyung-Hun;
    • Maur, Michela;
    • Pant, Shubham;
    • Kudo, Masatoshi;
    • Assenat, Eric;
    • Zhu, Andrew X.;
    • Yau, Thomas;
    • Lim, Ho Yeong
    Publication type:
    Article
    37
    38

    Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 11, p. 1991, doi. 10.1002/cncr.35226
    By:
    • Bishnoi, Sarwan;
    • Kotasek, Dusan;
    • Aghmesheh, Morteza;
    • Yau, Thomas;
    • Cosman, Rasha;
    • Prawira, Amy;
    • Moore, Maggie;
    • Chan, Stephen L.;
    • Mant, Andrew;
    • Eek, Richard;
    • Zielinski, Robert;
    • Su, Rila;
    • Pan, Zhaoxuan;
    • Ma, Yiding;
    • Li, Fei;
    • Li, Peiqi;
    • Tse, Archie N.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong.

    Published in:
    2016
    By:
    • Leung, Roland C. Y.;
    • Yau, Thomas C. C.;
    • Chan, Miranda C. M.;
    • Chan, Sharon W. W.;
    • Chan, Terence W. C.;
    • Tsang, Yvonne Y. Y.;
    • Ting Ting Wong;
    • Chao, Calvin;
    • Yoshizawa, Carl;
    • Soong, Inda S.;
    • Wing-Hong Kwan;
    • Kwok, Carol C. H.;
    • Suen, Joyce S. J.;
    • Ngan, Roger K. C.;
    • Cheung, Polly S. Y.;
    • Wong, Ting Ting;
    • Kwan, Wing-Hong
    Publication type:
    journal article
    45

    Pembrolizumab (Keytruda).

    Published in:
    Human Vaccines & Immunotherapeutics, 2016, v. 12, n. 11, p. 2777, doi. 10.1080/21645515.2016.1199310
    By:
    • Kwok, Gerry;
    • Yau, Thomas C. C.;
    • Chiu, Joanne W.;
    • Tse, Eric;
    • Kwong, Yok-Lam
    Publication type:
    Article
    46
    47
    48

    Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma.

    Published in:
    OncoImmunology, 2023, v. 12, n. 1, p. 1, doi. 10.1080/2162402X.2023.2214478
    By:
    • Koh, Benjamin;
    • Tan, Darren Jun Hao;
    • Lim, Wen Hui;
    • Wong, Jeffrey S L;
    • Ng, Cheng Han;
    • Chan, Kai En;
    • Wang, Meng;
    • Yong, Wei Peng;
    • Dan, Yock Young;
    • Wang, Louis Z;
    • Tan, Nigel;
    • Muthiah, Mark;
    • Kow, Alfred;
    • Syn, Nicholas L.;
    • Huang, Daniel Q.;
    • Yau, Thomas
    Publication type:
    Article
    49
    50

    A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma.

    Published in:
    Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919889001
    By:
    • Qin, Shukui;
    • Chan, Stephen Lam;
    • Sukeepaisarnjaroen, Wattana;
    • Han, Guohong;
    • Choo, Su Pin;
    • Sriuranpong, Virote;
    • Pan, Hongming;
    • Yau, Thomas;
    • Guo, Yabing;
    • Chen, Minshan;
    • Ren, Zhenggang;
    • Xu, Jianming;
    • Yen, Chia-Jui;
    • Lin, Zhong-Zhe;
    • Manenti, Luigi;
    • Gu, Yi;
    • Sun, Yongjian;
    • Tiedt, Ralph;
    • Hao, Lu;
    • Song, Wenjie
    Publication type:
    Article